10.3390/BIOMEDICINES12051131 24 NavarreteF
The most realistic UK timeline is MHRA approval in late 2027 to mid-2028, followed by NHS availability from 2029 at the earliest
Many individuals prescribed Mounjaro for type 2 diabetes or weight management also take other drugs for co-existing conditions like hypertension, high cholesterol, or other diabetes management
MT-2 is not intended for human consumption, veterinary use, self-administration, clinical use, treatment, diagnosis, prevention, cosmetic use, tanning use, supplement use, body composition use or any form of personal use